Implementation of Therapeutic and/or Abuse Drug Analysis in Blood Samples via Chemiluminescent Immunoassay Technique using the Randox Evidence Investigator™ Equipment

Article Fingerprint
Research ID 353HE

IntelliPaper

Abstract

The Toxicology Laboratory of the Instituto Nacional de Ciencias Forenses de Guatemala -INACIF- is responsible for analysing the biological signs in the search for chemical substances, among which drugs are found. Because Laboratories constantly need to update their technology, it was necessary to implement a new chemiluminescence immunoassay technique using the Randox Evidence Investigator TM kit. This technique is useful as it provides accurate and reproducible results. To implement this technique, 10 blood samples with a positive result for drugs habitually detected in the Toxicology Laboratory and 10 blood samples with a negative result for drugs were analysed, said analysis gave as a result the fulfilment of what was expected for positive and negative drugs. The time invested in analysis was also evaluated, which was approximately 4 to 4.5 hours.

Explore Digital Article Text

Article file ID not found.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

Not applicable

Data Availability

The datasets used in this study are openly available at [repository link] and the source code is available on GitHub at [GitHub link].

Funding

This work did not receive any external funding.

Cite this article

Generating citation...

Related Research

  • Classification

    LCC Code: RA1215

  • Version of record

    v1.0

  • Issue date

    19 November 2024

  • Language

    en

Article Placeholder
Open Access
Research Article
CC-BY-NC 4.0
Support